Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Head and Neck Cancer
Interventions: DRUG: Palbociclib|DRUG: Cetuximab|DRUG: Fulvestrant|DRUG: Letrozole
Sponsor: Pfizer